222 related articles for article (PubMed ID: 25220215)
1. Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability.
Kasparbauer AM; Rujescu D; Riedel M; Pogarell O; Costa A; Meindl T; la Fougère C; Ettinger U
Neuropsychopharmacology; 2015 Feb; 40(3):736-45. PubMed ID: 25220215
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3.
van de Giessen E; de Win MM; Tanck MW; van den Brink W; Baas F; Booij J
J Nucl Med; 2009 Jan; 50(1):45-52. PubMed ID: 19091889
[TBL] [Abstract][Full Text] [Related]
3. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies.
Costa A; Riedel M; Müller U; Möller HJ; Ettinger U
Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331
[TBL] [Abstract][Full Text] [Related]
4. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
van Dyck CH; Malison RT; Jacobsen LK; Seibyl JP; Staley JK; Laruelle M; Baldwin RM; Innis RB; Gelernter J
J Nucl Med; 2005 May; 46(5):745-51. PubMed ID: 15872345
[TBL] [Abstract][Full Text] [Related]
5. Association of COMT and SLC6A3 polymorphisms with impulsivity, response inhibition and brain function.
Kasparbauer AM; Merten N; Aichert DS; Wöstmann N; Meindl T; Rujescu D; Ettinger U
Cortex; 2015 Oct; 71():219-31. PubMed ID: 26245713
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective
Hellwig S; Frings L; Masuch A; Vach W; Domschke K; Normann C; Meyer PT
J Neural Transm (Vienna); 2018 Jun; 125(6):995-1005. PubMed ID: 29476250
[TBL] [Abstract][Full Text] [Related]
7. The role of the SLC6A3 3' UTR VNTR in nicotine effects on cognitive, affective, and motor function.
Schröder R; Reuter M; Faßbender K; Plieger T; Poulsen J; Lui SSY; Chan RCK; Ettinger U
Psychopharmacology (Berl); 2022 Feb; 239(2):489-507. PubMed ID: 34854936
[TBL] [Abstract][Full Text] [Related]
8. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
[TBL] [Abstract][Full Text] [Related]
10. Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis.
Faraone SV; Spencer TJ; Madras BK; Zhang-James Y; Biederman J
Mol Psychiatry; 2014 Aug; 19(8):880-9. PubMed ID: 24061496
[TBL] [Abstract][Full Text] [Related]
11. Genetic imaging study with [Tc-
Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
[TBL] [Abstract][Full Text] [Related]
12. A variable number of tandem repeats in the 3'-untranslated region of the dopamine transporter modulates striatal function during working memory updating across the adult age span.
Sambataro F; Podell JE; Murty VP; Das S; Kolachana B; Goldberg TE; Weinberger DR; Mattay VS
Eur J Neurosci; 2015 Aug; 42(3):1912-8. PubMed ID: 25997640
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics.
Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gassó P; Catalan R; Mateos JJ; Lomeña F; Parellada E
Schizophr Res; 2007 Feb; 90(1-3):115-22. PubMed ID: 17150335
[TBL] [Abstract][Full Text] [Related]
14. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
Krause J; la Fougere C; Krause KH; Ackenheil M; Dresel SH
Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):428-31. PubMed ID: 16091862
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease.
Habak C; Noreau A; Nagano-Saito A; Mejía-Constaín B; Degroot C; Strafella AP; Chouinard S; Lafontaine AL; Rouleau GA; Monchi O
Brain; 2014 Nov; 137(Pt 11):3025-35. PubMed ID: 25212851
[TBL] [Abstract][Full Text] [Related]
17. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
Cheon KA; Ryu YH; Kim JW; Cho DY
Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
[TBL] [Abstract][Full Text] [Related]
18. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.
Krause J; Dresel SH; Krause KH; La Fougère C; Zill P; Ackenheil M
World J Biol Psychiatry; 2006; 7(3):152-7. PubMed ID: 16861140
[TBL] [Abstract][Full Text] [Related]
19. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.
Spencer TJ; Biederman J; Faraone SV; Madras BK; Bonab AA; Dougherty DD; Batchelder H; Clarke A; Fischman AJ
Biol Psychiatry; 2013 Jul; 74(2):84-9. PubMed ID: 23273726
[TBL] [Abstract][Full Text] [Related]
20. The effects of DAT1 genotype on fMRI activation in an emotional go/no-go task.
Brown BK; Murrell J; Karne H; Anand A
Brain Imaging Behav; 2017 Feb; 11(1):185-193. PubMed ID: 26843006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
